Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
TEVAPHARMIND SP ADR (NY: TEVA)
17.19 USD  +0.04 (+0.23%)
Official Closing Price  /  Updated: 8:04 PM EDT, Sep 22, 2017  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 8,986,279
Open 17.21
Bid (Size) 17.17 (100)
Ask (Size) 17.18 (300)
Prev. Close 17.15
Today's Range 17.05 - 17.32
52wk Range 15.22 - 51.51
Shares Outstanding 1,016,000,000
Dividend Yield 6.43%
Performance
YTD
-54.14%
-54.14%
1 Month
+4.24%
+4.24%
3 Month
-47.29%
-47.29%
6 Month
-47.53%
-47.53%
1 Year
-66.45%
-66.45%
Top News
More News
TEVA PHARMACEUTICAL SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Teva Pharmaceutical Industries Limited
ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 23, 2017 to file lead plaintiff applications in a securities class action lawsuit against Teva... Read More
from PR Newswire
EQUITY ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Reminds Investors with Losses to Contact the Firm
from Accesswire RSS Master Feed
More News
Read More
Generic Drug Makers Face Pricing Issues Unlike Other Pharma Companies
category Technology
from Investor's Business Daily
Scott+Scott, Attorneys at Law, LLP Reminds Investors of October 23rd Lead Plaintiff Deadline in Class Action Against Teva Pharmaceutical Industries Ltd. (TEVA)
from PR Newswire
Big Business Starting to Look at Canada's Newest Industry
from PR Newswire
INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Encourages Investors with Losses to Contact the Firm
from Accesswire RSS Master Feed
Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Teva Pharmaceutical Industries Ltd. Investors and Encourages Investors to Contact the Firm (TEVA)
from Business Wire News Releases
SHAREHOLDER ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Reminds Investors with Losses to Contact the Firm
from Accesswire RSS Master Feed
EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Teva Pharmaceutical Industries Ltd. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 23, 2017 - TEVA
from Accesswire RSS Master Feed
Teva and Nuvelution Pharma Partner to Accelerate Development of AUSTEDO® (deutetrabenazine) Tablets for Use in Tourette Syndrome in the United States
from Business Wire News Releases
Teva Completes Amendment to Credit Facilities
from Business Wire News Releases
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial